Ticker >

Archit Organosys share price

Archit Organosys Ltd.

BSE: 524640 SECTOR: Chemicals  13k   42   5

48.87
+0.26 (0.53%)
BSE: 23 Feb 04:01 PM

Price Summary

Today's High

₹ 49.89

Today's Low

₹ 48

52 Week High

₹ 77.15

52 Week Low

₹ 45.8

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

100.28 Cr.

Enterprise Value

126.11 Cr.

No. of Shares

2.05 Cr.

P/E

28.2

P/B

1.61

Face Value

₹ 10

Div. Yield

1.03 %

Book Value (TTM)

₹  30.39

CASH

5.12 Cr.

DEBT

30.95 Cr.

Promoter Holding

62.37 %

EPS (TTM)

₹  1.73

Sales Growth

-7.34%

ROE

20.09 %

ROCE

19.96%

Profit Growth

38.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-7.34%
3 Year18.55%
5 Year9.4%

Profit Growth

1 Year38.82%
3 Year153.36%
5 Year86.34%

ROE%

1 Year20.09%
3 Year17.28%
5 Year7.37%

ROCE %

1 Year19.96%
3 Year16.48%
5 Year9.85%

Debt/Equity

0.5004

Price to Cash Flow

5.94

Interest Cover Ratio

7.98737042234394

CFO/PAT (5 Yr. Avg.)

2.56486771602553

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 62.37 0
Sep 2023 62.37 0
Jun 2023 62.37 0
Mar 2023 62.37 0
Dec 2022 61.64 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 18.5523121983217% for the Past 3 years.
  • Company’s PEG ratio is 0.726474563077529.
  • The company has an efficient Cash Conversion Cycle of 21.8449605888303 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.56486771602553.
  • The company has a high promoter holding of 62.37%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 22.42 46.55 31 26.39 24.81
Total Expenditure 18.84 43.63 27.75 24.08 23.71
Operating Profit 3.59 2.92 3.25 2.31 1.1
Other Income 0.19 1.35 0.71 0.54 0.52
Interest 0.52 0.51 0.53 0.85 0.77
Depreciation 1.31 1.16 1.19 1.49 1.49
Exceptional Items 1.65 0 0 0 0
Profit Before Tax 3.6 2.6 2.24 0.51 -0.64
Tax 1.36 0.59 0.6 0.14 -0.18
Profit After Tax 2.24 2.01 1.64 0.37 -0.46
Adjusted EPS (Rs) 1.09 0.98 0.8 0.18 -0.22

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 84 76.69 94.51 137.9 127.78
Total Expenditure 87 73.12 83.45 121.84 108.88
Operating Profit -3 3.57 11.06 16.06 18.9
Other Income 3.14 2.29 0.54 2.5 1.92
Interest 3.61 3.17 3.25 2.44 2.21
Depreciation 2.79 3.47 3.67 4.69 4.83
Exceptional Items 0 0 0 0 1.65
Profit Before Tax -6.26 -0.79 4.68 11.43 15.44
Tax -1.54 0.01 -0.32 3.19 4.01
Net Profit -4.72 -0.8 5.01 8.23 11.43
Adjusted EPS (Rs.) -3.14 -0.53 3.33 4.01 5.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 15.02 15.02 15.02 20.52 20.52
Total Reserves 19.9 19.09 25.52 31.37 41.33
Borrowings 17.78 12.4 12.11 12.21 14.2
Other N/C liabilities -0.49 0.45 -0.82 1.85 2.3
Current liabilities 32.68 35.66 34.58 39.44 46.15
Total Liabilities 84.89 82.61 86.41 105.39 124.5
Assets
Net Block 47.02 50.42 47.67 45.05 50.43
Capital WIP 4.85 1.08 2.98 12.75 13.79
Intangible WIP 0 0 0 0 0
Investments 0 0 0.3 1.4 3.75
Loans & Advances 0.78 0.76 0.99 1.43 1.39
Other N/C Assets 0 0 0 0.06 0.16
Current Assets 32.25 30.36 34.47 44.7 54.98
Total Assets 84.89 82.61 86.41 105.39 124.5
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -6.26 -0.79 4.68 11.43 15.44
Adjustment 5.84 6.08 7.5 6.36 4.16
Changes in Assets & Liabilities 3.35 2.53 -1.05 -5.7 0.45
Tax Paid -0.19 -0.08 -0.02 -1.47 -3.15
Operating Cash Flow 2.75 7.74 11.11 10.62 16.9
Investing Cash Flow 1.06 -0.82 -2.87 -11.52 -10.98
Financing Cash Flow 0.36 -8.87 -7.38 2.43 -6.14
Net Cash Flow 4.16 -1.95 0.86 1.54 -0.23

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 61.64 62.37 62.37 62.37 62.37
archana kandarp amin 21.30 21.30 21.30 21.30 21.30
archit kandarp amin 7.90 7.90 7.90 7.90 7.90
kandarp krishnakant amin 19.69 20.42 20.42 20.42 20.42
manini suchit amin 2.44 2.44 2.44 2.44 2.44
shimoli archit amin 2.44 2.44 2.44 2.44 2.44
suchit kandarp amin 7.88 7.88 7.88 7.88 7.88
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 38.36 37.63 37.63 37.63 37.63
llp 0.08 0.02 - 0.02 0.02
bhavana ankala 1.54 1.46 1.36 - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Archit Organosys - Quaterly Results14 Feb 2024, 6:28PM Archit Organosys incorporates subsidiary company22 Dec 2023, 10:12AM Archit Organosys submits annual report10 Aug 2023, 1:38PM Archit Organosys informs about issuance duplicate share certificate8 Aug 2023, 2:13PM Archit Organosys gets nod to transfer 81% stake in Archit Life Science19 Jun 2023, 9:25AM Archit Organosys informs about details of loss of certificate6 Jun 2023, 4:29PM Archit Organosys - Quaterly Results12 May 2023, 11:50PM Archit Organosys - Quaterly Results12 May 2023, 11:50PM Archit Organosys informs about board meeting3 May 2023, 12:23PM Archit Organosys informs about non-applicability of large corporate entity28 Apr 2023, 2:01PM Archit Organosys informs about disclosure 6 Mar 2023, 9:43AM Archit Organosys informs about disclosure4 Mar 2023, 4:00PM Archit Organosys informs about disclosure25 Feb 2023, 11:26AM Archit Organosys informs about disclosure 4 Feb 2023, 10:43AM Archit Organosys - Quaterly Results13 Jan 2023, 7:48PM Archit Organosys - Quaterly Results13 Jan 2023, 7:48PM Archit Organosys informs about loss of share certificates29 Dec 2022, 4:20PM Archit Organosys informs about disclosure16 Sep 2022, 12:02PM Archit Organosys incorporates Wholly Owned Subsidiary3 Sep 2022, 9:24AM Archit Organosys informs about disclosure 30 Aug 2022, 4:21PM Archit Organosys informs about disclosure 26 Aug 2022, 10:14AM Archit Organosys informs about disclosure30 Jul 2022, 11:08AM Archit Organosys informs about disclosure26 Jul 2022, 5:02PM Archit Organosys gets nod to incorporate new wholly owned subsidiary 26 Jul 2022, 11:18AM Archit Organosys - Quaterly Results25 Jul 2022, 5:45PM Archit Organosys - Quaterly Results25 Jul 2022, 5:45PM Archit Organosys - Quaterly Results12 May 2022, 7:14PM Archit Organosys - Quaterly Results12 May 2022, 7:14PM Archit Organosys informs about loss of share certificates21 Jan 2022, 3:25PM Archit Organosys informs about loss of share certificates9 Dec 2021, 4:14PM Archit Organosys informs about loss of share certificates26 Nov 2021, 2:55PM Archit Organosys gets nod to expand existing production capacity22 Sep 2021, 9:44AM Archit Organosys informs about newspaper publication25 Aug 2021, 4:40PM Archit Organosys informs about disclosure14 Jun 2021, 4:30PM Archit Organosys informs about disclosure1 Jun 2021, 4:37PM Archit Organosys informs about loss of certificate21 Apr 2021, 3:25PM Archit Organosys informs about annual report7 Sep 2020, 3:38PM

Archit Organosys Stock Price Analysis and Quick Research Report. Is Archit Organosys an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Archit Organosys has a PE ratio of 28.2012810895031 which is high and comparatively overvalued .

  • Share Price: - The current share price of Archit Organosys is Rs 48.87. One can use valuation calculators of ticker to know if Archit Organosys share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Archit Organosys has ROA of 9.94177460224245 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Archit Organosys has a Current ratio of 1.19127589494669 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Archit Organosys has a ROE of 20.0924161116308 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Archit Organosys has a D/E ratio of 0.5004 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Archit Organosys has an Inventory turnover ratio of 27.4250485582753 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Archit Organosys has reported revenue growth of -7.33701859381425 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Archit Organosys for the current financial year is 14.7930591651935 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Archit Organosys is Rs 0.5 and the yield is 1.0286 %.

Last Updated on:
Brief about Archit Organosys
X